USANA HEALTH SCIENCES INC Cash Flow Statement
USNA|13 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
USANA HEALTH SCIENCES INC generated $71M in operating cash flow and $56M in free cash flow in FY2025. Free cash flow margin was 6.1% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $63.8M | $69.3M | $124.7M | $126.2M | $62.5M | $100.0M | $94.7M | $76.6M | $79.0M | $66.4M | $50.8M | $45.7M | $33.6M |
| Depreciation & Amortization | $12.7M | $13.4M | $13.7M | $16.8M | $16.1M | $13.5M | $10.0M | $8.8M | $9.0M | $8.8M | $8.5M | $7.9M | $7.1M |
| Operating Cash Flow | $70.6M | $103.9M | $160.4M | $152.1M | $123.8M | $136.9M | $111.5M | $105.2M | $98.9M | $92.8M | $70.1M | $66.1M | $32.5M |
| Capital Expenditures | $14.5M | $10.4M | $15.1M | $11.4M | $13.2M | $32.7M | $23.7M | $20.4M | $8.1M | $8.4M | $10.6M | $4.2M | $4.1M |
| Free Cash Flow | $56.1M | $93.5M | $145.3M | $140.7M | $110.6M | $104.2M | $87.7M | $84.8M | $90.8M | $84.4M | $59.5M | $61.9M | $28.3M |
| Share Buybacks | $11.6M | $25.4M | $57.0M | $105.4M | $50.0M | $64.6M | $61.2M | $138.8M | $18.1M | $68.3M | $33.5M | $17.0M | $1.7M |
| FCF Margin | 6.1% | 9.4% | 12.8% | 11.8% | 10.6% | 10.4% | 9.6% | 10.7% | 12.7% | 13.0% | 10.2% | 12.0% | 6.5% |